Professor, Departments of Pharmacology and Biochemistry & Biophysics;
Member, Lineberger Comprehensive Cancer Center
John Sondek received his Ph.D. in Biochemistry from Johns Hopkins University in 1992. Upon completing postdoctoral studies at Yale University in 1996 as a Damon-Runyon-Walter Winchell Fellow, he joined the University of North Carolina at Chapel Hill, was named a Pew Scholar in the Biomedical Sciences, and is now a Professor in the Departments of Pharmacology, and Biochemistry & Biophysics as well as a member of the Lineberger Comprehensive Cancer Center. His independent research program has been continuously funded since its inception from various agencies including the National Institutes of Health, GlaxoSmithKline and the Pew Charitable Trusts.
His research is focused on understanding protein complexes involved in signal transduction cascades as potential targets for new therapeutics against cancer and neurological diseases. Additionally, he is an investigator on a new NIH program project to develop high-throughput technologies to study protein-protein interactions. He has authored or co-authored over 60 original research articles and holds three patents related to the mutagenesis and screening of proteins.
